Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperpolarized 13-C Pyruvate MRI Surveillance of Multiple Cancers
NCT05697406Phase 2Recruiting
- Sponsor
- University of Maryland, Baltimore
- Start
- Jun 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hyperpolarized 13C-pyruvate in cancer, sponsored by University of Maryland, Baltimore. Started Jun 2024; status: recruiting.
02
Drugs
hyperpolarized 13C-pyruvate
03
Conditions
cancer
Beyond the preview
Go deeper on NCT05697406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05697406.